Bliss GVS Pharma Ltd Share Price

Q: What is the share price of Bliss GVS Pharma Ltd today?

Bliss GVS Pharma Ltd share price as on 16 May 2025 is ₹112.07

Pharmaceuticals

NSE: BLISSGVS Small Cap ISIN: INE416D01022

As on 16 May 2025 at 20:33 IST

₹ 112.07

-3.30

(-2.86%)

Sell Buy

Over 1 Month

-1.03%

Over 6 Months

-8.99%

Over 1 Year

2.73%

Over 3 Years

53.93%

Bliss GVS Pharma Ltd Summary

Close ₹115.37

Open ₹110.26

High ₹115.85

Low ₹110.05

Volume 1,88,150

Net Turnover (in Cr) ₹2.14

52Wk High ₹185.50

52Wk Low ₹92.15

52Wk High / Low

92.15

185.50

Bliss GVS Pharma Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹1,215.66

EPS (TTM) 7.70

Book Value (BV) 97.23

Div. Yield 0.43 %

P/E (TTM) 26.45

Price/Book Value 1.19

Delivery % 38.74 %

Face Value 1

Key Ratios

PE Ratio 23.27

PB Ratio 1.19

EV to Sales 1.80

PEG Ratio -0.57

ROA 4.74

ROE 7.91

Debt-Equity 0.08

Net Profit Margin 12.57

Operating Profit Margin 23.18

Bliss GVS Pharma Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	798.98	769.37	778.95	597.43	728.49
Total Expenses	652.91	663.30	651.19	493.30	586.15
Profit Before Tax	116.87	106.07	54.17	104.13	128.97
Profit After Tax	81.58	76.73	23.13	73.97	95.25
Operating Profit After Depreciation	152.98	116.44	132.50	109.64	149.91

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	369.37	378.05	280.76	233.72	240.97
Total Non Current Assets	402.25	459.49	331.89	311.59	257.48
Total Current Assets	811.62	697.37	776.86	765.20	769.74
Total Assets	1,213.87	1,156.85	1,108.75	1,076.79	1,027.22
Total Shareholder's Fund	967.19	883.90	818.70	808.25	735.61

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash From Operating Activities	152.45	34.31	135.48	63.97	46.70
Net Cash Used In Investing Activities	-132.97	-6.36	-102.90	-45.38	-40.09
Net Cash Used In Financing Activities	-20.89	-24.94	-23.73	-20.80	-6.30

Profit and Loss

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	638.96	649.11	668.98	483.20	476.88
Total Expenses	527.62	533.41	545.33	392.01	355.17
Profit Before Tax	70.26	115.69	126.40	91.19	121.71
Profit After Tax	50.64	85.48	92.66	67.50	92.33
Operating Profit After Depreciation	117.15	125.75	127.98	95.38	126.27

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	329.95	324.82	224.31	174.10	178.86
Total Non Current Assets	379.57	410.04	288.22	268.98	211.05
Total Current Assets	772.98	729.65	791.74	676.64	644.05
Total Assets	1,152.55	1,139.69	1,079.96	945.62	855.10
Total Shareholder's Fund	988.44	937	851.43	755.65	682.94

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash From Operating Activities	125.92	43.81	114.05	66.97	63.22
Net Cash Used In Investing Activities	-109.59	-12.97	-92.28	-61.62	-60.14
Net Cash Used In Financing Activities	-20.76	-26.05	-12.62	-11.67	-5.83

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	210.42	217.68	183.64	198.13	200.72
Total Expenses	180.63	176.20	149.31	169.78	157.03
Profit Before Tax	36.43	35.71	30.07	-3.95	40.04
Profit After Tax	25.80	25.69	22.11	-4.91	29.07
Operating Profit after Depreciation	45.06	46.52	38.45	33.95	49.11

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	179.59	182.65	148.96	163.82	161.33
Total Expenses	153.86	157.27	122.22	138.67	132.67
Profit Before Tax	29.76	23.89	26.15	-15.24	28.52
Profit After Tax	21.05	17.04	19.42	-11.46	20.72
Operating Profit after Depreciation	37.39	33.73	33.58	33.61	36.56

Bliss GVS Pharma Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 111.66

S2 107.96

S3 105.86

Pivot 113.76

R1 117.46

R2 119.56

R3 123.26

Moving Average

20 SMA 120.75

50 SMA 122.68

100 SMA 140.86

200 SMA 134.12

Bliss GVS Pharma Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Bliss GVS Pharma Ltd

₹0.5/Share

Announcement Date 18 Jul 2024

Record Date 19 Jul 2024

Div Yield 50%

AGM Date: 28 Jun 2022

Outcome Of Board Meeting Held On Saturday, April 30, 2022 37th AGM of the Company for the Financial Year 2021-2022 has been scheduled to be held on Tuesday, June 28, 2022 at 11:00 a.m. through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') facility Pursuant to Section 91 of the Companies Act, 2013 ('Act'') and applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with our intimation submitted to you w.r.t. Final Dividend on April 30, 2022, the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday, June 22, 2022 to Thursday, June 28, 2022 (both the days inclusive) for taking on record of the members of the Company for the purpose of holding 37th Annual General Meeting of the Company which will be held on Thursday, June 28, 2022 for the financial year ended March 31, 2022 and payment of Final Dividend for the financial year 2021-2022. (As Per BSE Announcement Dated on 30.04.2022) Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of advertisement of public notice issued in respect of information regarding 37th Annual General Meeting of the Company scheduled to be held on Tuesday, June 28, 2022 at 11:00 a.m. (IST) through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'), in compliance with the General Circulars dated April 08, 2020, April 13, 2020, May 05, 2020 and January 13, 2021, December 08, 2021, December 14, 2021 and May 05, 2022 respectively issued by the Ministry of Corporate Affairs ('MCA Circulars') along with the Circular issued by Securities and Exchange Board of India ('SEBI Circular') dated May 12, 2020, January 15, 2021 and May 13, 2022 published in Free Press Journal and Navshakti - Mumbai newspapers on May 30, 2022. (As Per BSE Announcement Dated on 30/05/2022) We would like to inform you that 37th Annual General Meeting of the Company was held today i.e. Tuesday, June 28, 2022 at 11:00 a.m., being requisite quorum present, meeting commenced at 11:00 a.m., through Video Conferencing ('VC')/Other Audio Visual Means ('OVAM') as attached herewith for your reference. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith proceedings of the 37th Annual General Meeting held on Tuesday, June 28, 2022 at 11:00 am through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM'). Kindly take the above intimation in your record. (As Per BSE Announcement Dated on 28.06.2022) In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 37th Annual General Meeting of the Company held on Tuesday, June 28, 2022 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the 37th Annual General Meeting. (As per BSE Announcement Dated on 29/06/2022) Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 30.06.2022)

AGM Date: 19 Jul 2023

Pursuant to Section 91 of the Companies Act, 2013 ('Act'') and applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with our intimation submitted to you w.r.t. Final Dividend on May 11, 2023, the Register of Members and Share Transfer Books of the Company will remain closed from Thursday, July 13, 2023 to Wednesday, July 19, 2023 (both the days inclusive) for taking on record of the members of the Company for the purpose of holding 38th Annual General Meeting of the Company which will be held on Wednesday, July 19, 2023 for the financial year ended March 31, 2023 and payment of Final Dividend for the financial year ended March 31, 2023. Please find enclosed herewith Outcome of 38th Annual General Meeting ('AGM') of the Company held today i.e. Wednesday, July 19, 2023. Please find enclosed herewith proceedings of the 38th Annual General Meeting held on Wednesday, July 19, 2023 at 11:00 a.m. through Video Conferencing ('VC')/Other Audio-Visual Means ('OVAM'). (As per BSE Announcement Dated on 19/07/2023) In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 38th Annual General Meeting of the Company held on Wednesday, July 19, 2023 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the 38th Annual General Meeting. (As Per BSE Announcement Dated on 20/07/2023)

AGM Date: 25 Jul 2024

We would like to inform you that, the Board Meeting of the Company was held today i.e. Thursday, May 02, 2024 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the matters amongst others as attached. According to section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirments) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Friday, July 19, 2024 to Thursday, July 25, 2024 (both days inclusive) for taking on record of the members of the Company for the purpose of holding 39th Annual General Meeting of the Company which will be held on Thursday. July 25, 2024, for the financial year ended March 31, 2024 and payment of Final Dividend for the financial year ended March 31, 2024. Enclosed herewith proceedings of the 39th Annual General Meeting held on Thursday, July 25, 2024 at 11:00 a.m. through VC/OAVM. (As Per BSE Announcement Dated on: 25/07/2024)

Bliss GVS Pharma Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,781.35	₹4,27,405.53
Divis Laboratories Ltd	₹6,144.35	₹1,63,113.19
Cipla Ltd	₹1,508.95	₹1,21,868.90
Torrent Pharmaceuticals Ltd	₹3,289.90	₹1,11,340.16
Mankind Pharma Ltd	₹2,430.05	₹1,00,258.65

Bliss GVS Pharma Ltd Top Mutal Funds Invested

Fund Name	AUM
Bandhan BSE Healthcare Index Fund	0.06%

Bliss GVS Pharma Ltd News

Bliss GVS Pharma to announce Quarterly Result

On 12 May 2025

06 May 2025, 11:50 am

Bliss GVS Pharma invokes arbitration proceedings against Pan Pharmaceuticals, Kenya

For recovery of outstanding dues

03 May 2025, 11:27 am

Bliss GVS Pharma schedules board meeting

On 28 January 2025

22 Jan 2025, 09:41 am

Bliss GVS Pharma allots 34,250 equity shares under ESOP

06 Dec 2024, 07:02 pm

Bliss GVS Pharma soars after manufacturing units get GMP certificate from Romania medical authority

Bliss GVS Pharma jumped 5.10% to Rs 138.20 after the company's Maharashtra-based facilities received a GMP compliance certificate from the National Agency for Medicines and Medical Devices of Romania post an EU GMP inspection.

25 Nov 2024, 09:40 am

Bliss GVS Pharma Ltd Stock Analysis

Annual revenue for Bliss GVS Pharma Ltd decreased by 1.56% to ₹638.96 crore in FY 2024 from ₹649.11 crore in FY 2023.
Annual Net Profit for Bliss GVS Pharma Ltd decreased by 40.75% to ₹50.64 crore in FY 2024 from ₹85.48 crore in FY 2023.
Promoter Shareholding in Bliss GVS Pharma Ltd increased by 0.54% in the most recent quarter, from 35.10% in December 2024 to 35.29% in March 2025.
Bliss GVS Pharma Ltd delivered a 1-year return of 2.73% compared to the Nifty 50, which provided a return of 9.47% as of the last trading session.
Bliss GVS Pharma Ltd share price moved down by 2.86% from its previous close of INR ₹115.37. The latest Bliss GVS Pharma Ltd share price is INR ₹112.07.
Bliss GVS Pharma Ltd share price today has been at a low of 111.01 and a high of 116.99. Over the past 52 weeks, the Bliss GVS Pharma Ltd share price has seen a low of 92.15 and a high of 185.50.